These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11138292

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 23. Gemfibrozil, lipids, and coronary risk.
    Rifkind BM.
    N Engl J Med; 1987 Nov 12; 317(20):1279-81. PubMed ID: 3313042
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Lipid lowering: myth or therapeutic necessity?].
    Dtsch Med Wochenschr; 1998 Oct 02; 123(40 Suppl):2-8. PubMed ID: 9793486
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Medical recommendations and references about hypolipidemic drugs. ANDEM (National Agency for the Development of Medical Evaluation].
    J Mal Vasc; 1997 Oct 02; 22(4):249-64. PubMed ID: 9411011
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Oct 02; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

  • 35. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL, Blazing MA, Saxena S, Guyton JR.
    J Cardiovasc Risk; 2002 Dec 02; 9(6):339-47. PubMed ID: 12478203
    [Abstract] [Full Text] [Related]

  • 36. Risk reduction strategies in coronary artery disease.
    Gibson TM, Ratts T.
    J La State Med Soc; 2001 Jun 02; 153(6):312-9. PubMed ID: 11480382
    [Abstract] [Full Text] [Related]

  • 37. Women with heart disease may need aggressive treatment for high cholesterol.
    Int J Fertil Womens Med; 1997 Jun 02; 42(3):182. PubMed ID: 9222800
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W.
    MMW Fortschr Med; 2005 Apr 07; 147(14):14. PubMed ID: 15887675
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.